Skip to main content

Select Drug Profiles

Practice Management
FDA Bolsters Its Generic Approval Process: Health Plans Reap the Benefits
Read More
FDA Approvals
Heparin at the Center of the Storm
Mark Senak, JD
Read More
Original Research
Prescribing Warfarin Appropriately to Meet Patient Safety Goals
Lekshmi Dharmarajan, MD, FACP, FACC, T. S. Dharmarajan, MD, FACP, AGSF
Stakeholder Perspective
Benefits of Genetic Testing in Warfarin Therapy
by Teresa DeLuca, MD, MBA
Read More
Practice Management
Treading Water: The No-Growth Investment in Health Services Research
Emily J. Holubowich, MPP, Joseph R. Antos, PhD
Stakeholder Perspective
The Golden Age of Health Services Research
by Joseph R. Antos, PhD
Read More
Conference Highlights ISPOR
The International Society for Pharmacoeconomics and Outcomes Research: Implications for Decision Makers in Healthcare
Gordon M. Cummins, MS
Read More
Conference Highlights ISPOR
Select Topics from ISPOR, May 2008
Read More
Perspectives
The Governing Dynamics of the Healthcare Universe: Thinking Lagrangian
Robert E. Henry
Read More
Perspectives
Quality in the Pharmacy Environment
Jan E. Berger, MD, MJ
Read More
Practice Management
Delaware's Wellness Program: Motivating Employees Improves Health and Saves Money
Jennifer "J.J" Davis
Stakeholder Perspective
The Lessons from Delaware's Employee Benefits Program
by F. Randy Vogenberg, PhD, FASHP
Read More
Practice Management
Switching to Generic Antiepileptic Drugs: Growing Concerns
Dalia Buffery, MA, ABD
Read More
Page 234 of 244
Results 2331 - 2340 of 2438